Bay Area Company wins $30,000 in 2016 BioSciKin Competition for Life Science Start-Ups
California Preliminary Selects Winners for Final Competition in Shanghai
South San Francisco-based Fibralign Corporation took first place in the Bay Area Preliminary of the 2016 BioSciKin Competition for Life Science Start-ups, winning $30,000 and the invitation to the final competition in Shanghai for their proprietary thread-like collagen scaffold platform that addresses a wide range of high-value applications in the fields of tissue engineering. The competition, which took place on April 7, 2016 at Stanford University, was among a series of international contests that are taking place in eight locations in the United States and China. The second-place winner, San Diego-based Denovo Biopharma, with its novel biomarker technology and capital efficient model to personalize drug development, will receive a free round-trip to compete in the final competition round, which will take place on June 25, 2016 in Shanghai, China.
The 2016 BioSciKin Competition for Life Science Start-Ups launched in January 2016 in Massachusetts, California and eight Chinese cities. Ten contestants have been selected in each U.S. Preliminary to showcase their business plans, with ideas ranging from innovative drug development, cell therapy, immunotherapy, medical device to molecular diagnostics. Contestants were screened and selected from over 150 submissions. A panel of judges, consisting of renowned investment experts predominantly from the United States, selected winners on the basis of overall team competency, scientific rationale and impact of innovation, IP legitimacy, market prospective, regulatory landscape and overall presentation performance.
Dr. Lin Wu, Vice President of Development for the Sequencing Business Unit of Roche Diagnostics, gave the keynote address on non-invasive liquid biopsy for cancer patients. The event also included remarks from Dr. Penghui Xu, Science Consul from Consulate General of the People’s Republic of China in San Francisco, and Dr. Cheni Kwok, President-elect of Chinese American Biopharmaceutical Society (CABS). The event was organized and supported by CABS, the California Life Sciences Association (CLSA), the California Life Sciences Institute (CLSI) and the Association of Chinese Students and Scholars at Stanford (ACSSS). Ray Zhang from BioSciKin is the overall leader for BSK contests in China and the US; while Yan Wang from CABS is the leader for organizing the preliminary in the San Francisco Bay Area.
BioSciKin (BSK) is an open platform in China for life science entrepreneurs and innovators. Focuses on three major healthcare areas: novel therapeutics, medical devices and mobile healthcare services, BSK is looking for partnership from all over the world for co-development of innovative approaches in precision medicine. In Nanjing, Shanghai and Tianjin, BSK has established 3 R&D-oriented incubation parks with advanced R&D facilities to provide entrepreneurs with customized service and support packages. For more information, please go to BSK’s official website: www.bioscikin.com. For more information, please contact Ms. Ray Zhang, Senior BD Director, BioSciKin: firstname.lastname@example.org